Sol-Gel Technologies(SLGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SLGL Sol-Gel Technologies

Closed 12-31 16:00:00 EST

42.14

-0.32

-0.75%

盘后42.67

+0.53+1.26%

19:56 EST

High43.30	Low41.66	Vol37.85K
Open42.53	D1 Closing42.46	Amplitude3.86%
Mkt Cap117.39M	Tradable Cap29.05M	Total Shares2.79M
T/O1.59M	T/O Rate5.49%	Tradable Shares689.35K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SLGL","market":"US","secType":"STK","nameCN":"Sol-Gel Technologies","latestPrice":42.14,"timestamp":1767214800000,"preClose":42.46,"halted":0,"volume":37853,"hourTrading":{"tag":"盘后","latestPrice":42.67,"preClose":42.14,"latestTime":"19:56 EST","volume":655,"amount":28085.92,"timestamp":1767228996188},"delay":0,"floatShares":689345,"shares":2785787,"eps":-3.225688,"marketStatus":"Closed","change":-0.32,"latestTime":"12-31 16:00:00 EST","open":42.53,"high":43.3,"low":41.66,"amount":1592968.821031,"amplitude":0.038625,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.225688,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1767344400000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1517461200000,"exchange":"NASDAQ","adjPreClose":42.46,"postHourTrading":{"tag":"盘后","latestPrice":42.67,"preClose":42.14,"latestTime":"19:56 EST","volume":655,"amount":28085.92,"timestamp":1767228996188},"volumeRatio":1.016625,"impliedVol":1.504,"impliedVolPercentile":0.9881},"requestUrl":"/m/hq/s/SLGL","defaultTab":"news","newsList":[{"id":"2595758456","title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2595758456","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595758456?lang=en_us&edition=fundamental","pubTime":"2025-12-30 05:06","pubTimestamp":1767042376,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a beneficial owner, has reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 29, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL9ZGcRV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2593481009","title":"Sol-Gel Technologies Price Target Maintained With a $50.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2593481009","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593481009?lang=en_us&edition=fundamental","pubTime":"2025-12-22 19:33","pubTimestamp":1766403180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SLGL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 22, 2025 06:33 ET (11:33 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL"],"gpt_icon":0},{"id":"2592197428","title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592197428","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592197428?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:06","pubTimestamp":1766178366,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a 10% owner, reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL6yLVpy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2592948586","title":"Sol-Gel to End SGT-210 Trial in Darier Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2592948586","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592948586?lang=en_us&edition=fundamental","pubTime":"2025-12-18 04:08","pubTimestamp":1766002118,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies  said Wednesday data from its phase 1b trial of SGT-210 in Darier Disease did not show differentiation between SGT-210 and vehicle on efficacy following unblinding.\"The study did not demonstrate a signal of superiority of active treatment versus vehicle,\" said Executive Chairman Mori Arkin. \"We have therefore decided not to advance to the next stage of development in this indication.\"Arkin said the firm plans to pursue \"very\" small, low-cost feasibility studies in other areas where the mechanistic rationale for SGT-210 is strong.Shares of Sol-Gel were over 2% lower in recent trading.Price: 41.25, Change: -0.88, Percent Change: -2.08","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2592591088","title":"Why Is Small Cap Sol-Gel Tech Stock Falling Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2592591088","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592591088?lang=en_us&edition=fundamental","pubTime":"2025-12-18 02:47","pubTimestamp":1765997220,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies ends development of SGT-210 in Darier disease after Phase 1b data show no efficacy versus vehicle.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/17/Medical-Development-Laboratory-Caucasian.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/17/Medical-Development-Laboratory-Caucasian.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/12/49459762/why-is-small-cap-sol-gel-tech-stock-falling-today","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49459762/why-is-small-cap-sol-gel-tech-stock-falling-today","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2592992310","title":"Sol Gel Technologies Ltd - Phase 1B Study of Sgt-210 Shows No Differentiation From Vehicle","url":"https://stock-news.laohu8.com/highlight/detail?id=2592992310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592992310?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:00","pubTimestamp":1765972803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA6RCC4T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2592923179","title":"Sol Gel Technologies Ltd - Sol-Gel Decides Not to Advance Sgt-210 to Next Development Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2592923179","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592923179?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:00","pubTimestamp":1765972803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA6RCC4T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2592199231","title":"Sol Gel Technologies Ltd - Continue to Prioritize Phase 3 Program of Sgt-610 in Gorlin Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2592199231","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592199231?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:00","pubTimestamp":1765972803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA6RCC4T:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2592516992","title":"Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2592516992","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592516992?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:00","pubTimestamp":1765972800,"startTime":"0","endTime":"0","summary":"NESS ZIONA, Israel, Dec.  17, 2025  (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd.(NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/17/3206873/0/en/Sol-Gel-Provides-Update-Following-Unblinding-of-Phase-1b-Study-of-SGT-210-in-Darier-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2592937920","title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592937920","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592937920?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:06","pubTimestamp":1765919168,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc. has reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL9JHBLQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2590321772","title":"Opaleye Management Acquires Common Shares of Sol Gel Technologies Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2590321772","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590321772?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:12","pubTimestamp":1765314762,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a beneficial owner, has reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL9WbbN3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Acquires Common Shares of Sol Gel Technologies Ltd","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2588271310","title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588271310","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588271310?lang=en_us&edition=fundamental","pubTime":"2025-12-04 06:39","pubTimestamp":1764801572,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a beneficial owner, has reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL91K9dy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2586260131","title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586260131","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586260131?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:06","pubTimestamp":1764191174,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a beneficial owner, reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL9s6tjK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2585125279","title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2585125279","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585125279?lang=en_us&edition=fundamental","pubTime":"2025-11-22 05:06","pubTimestamp":1763759191,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., as a beneficial owner, has reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 21, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDL5zwYjf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2584394137","title":"Sol-Gel Technologies Announces Q3 2025 Financial Results and Strategic Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2584394137","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584394137?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:54","pubTimestamp":1763646864,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies ( ($SLGL) ) just unveiled an announcement. On November 20, 2025, Sol-Gel Technologies announced its financial results for the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sol-gel-technologies-announces-q3-2025-financial-results-and-strategic-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sol-gel-technologies-announces-q3-2025-financial-results-and-strategic-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2584613465","title":"BRIEF-Sol Gel Technologies Ltd Phase 3 Trial Of Sgt-610 For Gorlin Syndrome Is Ongoing,Top-Line Results Expected Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2584613465","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584613465?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:14","pubTimestamp":1763644477,"startTime":"0","endTime":"0","summary":"BRIEF-Sol Gel Technologies Ltd Phase 3 Trial Of Sgt-610 For Gorlin Syndrome Is Ongoing,Top-Line Results Expected Q4 2026Sol Gel Technologies Ltd SLGL.O:SOL GEL TECHNOLOGIES LTD: PHASE 3 TRIAL OF SGT-6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nFWN3WW0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2584390301","title":"Sol-Gel Technologies reports Q3 EPS ($2.13) vs (13c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2584390301","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584390301?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:36","pubTimestamp":1763642161,"startTime":"0","endTime":"0","summary":"Reports Q3 revenue $400k vs $5.4M last year. Mori Arkin, Executive Chairman of Sol-Gel, stated: “Sol-Gel continued to make steady progress in the t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sol-gel-technologies-reports-q3-eps-2-13-vs-13c-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sol-gel-technologies-reports-q3-eps-2-13-vs-13c-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLGL"],"gpt_icon":0},{"id":"2584139400","title":"Sol Gel Technologies Ltd: Expects Its Cash Resources to Fund Cash Requirements Into Q1 of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2584139400","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584139400?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:34","pubTimestamp":1763642094,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nFWN3WW0VV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2584139401","title":"Sol-Gel Technologies Q3 EPS $(2.13) Misses $(2.09) Estimate, Sales $400.000K Beat $300.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2584139401","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584139401?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:34","pubTimestamp":1763642056,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies (NASDAQ:SLGL) reported quarterly losses of $(2.13) per share which missed the analyst consensus estimate of $(2.09) by 1.91 percent. This is a 1538.46 percent decrease over losses of $(0.13) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48972077/sol-gel-technologies-q3-eps-2-13-misses-2-09-estimate-sales-400-000k-beat-300-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL"],"gpt_icon":0},{"id":"2584139148","title":"Press Release: Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2584139148","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584139148?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:30","pubTimestamp":1763641800,"startTime":"0","endTime":"0","summary":"-- Sol-Gel intends to pursue high-frequency BCC as an additional indication. for its lead drug candidate SGT-610, which, if approved, could at least. -- In September 2025, Sol-Gel announced Health Canada approval of EPSOLAY. -- Sol-Gel signed an additional agreement with Viatris covering Australia. NESS ZIONA, Israel, Nov. 20, 2025  -- Sol-Gel Technologies, Ltd. , a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today announced financial results for the third quarter ending September 30, 2025, and provided a corporate update.-- Sol-Gel's ongoing Phase 3 clinical trial of SGT-610 . for Gorlin syndrome, for which top-line results are expected in the. fourth quarter of 2026, has led to growing physician interest in its. potential use in patients with severe, high-frequency basal cell. devastating form of high-frequency BCC, was found to have a lesion. harboring a PTCH-1 mutation, and Sol-Gel agreed to provide SGT-610 for. compassionate use. S","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","SOL.USD.HKCC","BK4583","BK4585","BK4104","BCC","BK4588","LU2087621335.USD","BK4007","SLGL","BK4567","AVAX.USD.HKCC","VTRS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sol-gel.com","stockEarnings":[{"period":"1week","weight":-0.0164},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.4393},{"period":"6month","weight":4.6879},{"period":"1year","weight":2.7911},{"period":"ytd","weight":3.5651}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.0053},{"period":"3month","weight":0.0278},{"period":"6month","weight":0.0986},{"period":"1year","weight":0.1679},{"period":"ytd","weight":0.1722}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.015608},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.077333},{"month":3,"riseRate":0.25,"avgChangeRate":-0.056039},{"month":4,"riseRate":0.375,"avgChangeRate":0.000899},{"month":5,"riseRate":0.5,"avgChangeRate":0.013217},{"month":6,"riseRate":0.625,"avgChangeRate":-0.011897},{"month":7,"riseRate":0.5,"avgChangeRate":0.06768},{"month":8,"riseRate":0.5,"avgChangeRate":0.113954},{"month":9,"riseRate":0.5,"avgChangeRate":-0.011791},{"month":10,"riseRate":0.25,"avgChangeRate":-0.064677},{"month":11,"riseRate":0.625,"avgChangeRate":0.040189},{"month":12,"riseRate":0.5,"avgChangeRate":0.188849}],"exchange":"NASDAQ","name":"Sol-Gel Technologies","nameEN":"Sol-Gel Technologies"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sol-Gel Technologies(SLGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Sol-Gel Technologies(SLGL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Sol-Gel Technologies,SLGL,Sol-Gel Technologies股票,Sol-Gel Technologies股票老虎,Sol-Gel Technologies股票老虎国际,Sol-Gel Technologies行情,Sol-Gel Technologies股票行情,Sol-Gel Technologies股价,Sol-Gel Technologies股市,Sol-Gel Technologies股票价格,Sol-Gel Technologies股票交易,Sol-Gel Technologies股票购买,Sol-Gel Technologies股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sol-Gel Technologies(SLGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Sol-Gel Technologies(SLGL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction